BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 33176942)

  • 1. Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108395. PubMed ID: 33176942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Van Hoof D; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108441. PubMed ID: 33250386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum.
    Stiles MF; Campbell LR; Jin T; Graff DW; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2018 Jul; 235(7):2077-2086. PubMed ID: 29725702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers.
    Goldenson NI; Fearon IM; Buchhalter AR; Henningfield JE
    Nicotine Tob Res; 2021 May; 23(6):947-955. PubMed ID: 33486526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.
    Stiles MF; Campbell LR; Graff DW; Jones BA; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2017 Sep; 234(17):2643-2655. PubMed ID: 28634710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI
    Fearon IM; Gilligan K; Seltzer RGN; McKinney W
    Harm Reduct J; 2022 Jun; 19(1):57. PubMed ID: 35655314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse liability of two electronic nicotine delivery systems compared with combustible cigarettes and nicotine gum from an open-label randomized crossover study.
    Campbell C; Jin T; Round EK; Nelson PR; Baxter S
    Sci Rep; 2023 Nov; 13(1):18951. PubMed ID: 37919490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of abuse liability and switching potential of menthol-flavored pod-based electronic nicotine delivery systems among US adults who smoke cigarettes.
    Goldenson NI; Shiffman S; Sembower MA; Black RA
    Drug Alcohol Depend; 2024 May; 258():111279. PubMed ID: 38614020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
    Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part one: abuse liability of Vuse Solo (G2) electronic nicotine delivery system relative to combustible cigarettes and nicotine gum.
    Campbell C; Jin T; Round EK; Schmidt E; Nelson P; Baxter S
    Sci Rep; 2022 Dec; 12(1):22080. PubMed ID: 36543869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.
    Cohen G; Goldenson NI; Bailey PC; Chan S; Shiffman S
    Nicotine Tob Res; 2021 Nov; 23(12):2153-2161. PubMed ID: 34161586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette.
    Goldenson NI; Augustson EM; Chen J; Shiffman S
    Psychopharmacology (Berl); 2022 Mar; 239(3):977-988. PubMed ID: 35184228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!® nicotine pouches compared to combustible cigarettes.
    Rensch J; Liu J; Wang J; Vansickel A; Edmiston J; Sarkar M
    Psychopharmacology (Berl); 2021 Nov; 238(11):3325-3334. PubMed ID: 34432106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.
    Voos N; Smith D; Kaiser L; Mahoney MC; Bradizza CM; Kozlowski LT; Benowitz NL; O'Connor RJ; Goniewicz ML
    Psychopharmacology (Berl); 2020 Feb; 237(2):491-502. PubMed ID: 31773209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of menthol/mint-flavored pods on young JUUL E-cigarette users' subjective experience, puffing behavior, and nicotine exposure: A pilot study.
    Li W; Vargas-Rivera M; Eissenberg TE; Shihadeh A; Talih S; Maziak W
    Drug Alcohol Depend; 2022 Aug; 237():109516. PubMed ID: 35679691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Day Changes in Biomarkers of Exposure Among Adult Smokers After Completely Switching From Combustible Cigarettes to a Nicotine-Salt Pod System.
    Jay J; Pfaunmiller EL; Huang NJ; Cohen G; Graff DW
    Nicotine Tob Res; 2020 Jul; 22(8):1285-1293. PubMed ID: 31688930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
    Cobb CO; Lopez AA; Soule EK; Yen MS; Rumsey H; Lester Scholtes R; Rudy AK; Lipato T; Guy M; Eissenberg T
    Drug Alcohol Depend; 2019 Oct; 203():27-34. PubMed ID: 31401532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse liability assessment of an electronic cigarette in combustible cigarette smokers.
    Maloney SF; Breland A; Soule EK; Hiler M; Ramôa C; Lipato T; Eissenberg T
    Exp Clin Psychopharmacol; 2019 Oct; 27(5):443-454. PubMed ID: 30777773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with past 30-day abstinence from cigarette smoking in a non-probabilistic sample of 15,456 adult established current smokers in the United States who used JUUL vapor products for three months.
    Russell C; Haseen F; McKeganey N
    Harm Reduct J; 2019 Mar; 16(1):22. PubMed ID: 30909979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy.
    Hardie G; Gale N; McEwan M; Oscar SM; Ziviani L; Proctor CJ; Murphy J
    Sci Rep; 2022 Aug; 12(1):14701. PubMed ID: 36038580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.